Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Perinatol ; 43(2): 215-219, 2023 02.
Article in English | MEDLINE | ID: mdl-36309565

ABSTRACT

OBJECTIVE: To assess the educational and clinical impact of a tiny baby intubation team (TBIT). STUDY DESIGN: Retrospective study comparing endotracheal intubation (ETI) performed: pre-implementation of a TBIT (T1), 6 months post-implementation (T2), and 4 years post-implementation (T3). RESULTS: Post-implementation (T2), first-attempt success rate in tiny babies increased (44% T1; 59% T2, p = 0.04; 56% T3, p = NS) and the proportion of ETIs performed by residents decreased (53% T1; 37% T2, p = 0.001; 45% T3, p = NS). After an educational quality improvement intervention (prioritizing non-tiny baby ETIs to residents, systematic simulation training and ETI using videolaryngoscopy), in T3 residents' overall (67% T1; 60% T2, p = NS; 79% T3, p = 0.02) and non-tiny baby ETI success rate improved (72% T1; 60% T2, p = NS; 82% T3, p = 0.02). CONCLUSION: A TBIT improves success rate of ETIs in ELBW infants but decreases educational exposure of residents. Educational strategies may help maintain resident procedural competency without impacting on quality of care.


Subject(s)
Clinical Competence , Intubation, Intratracheal , Infant , Humans , Retrospective Studies , Educational Status , Quality Improvement
2.
Arch Pediatr ; 24(2): 146-154, 2017 Feb.
Article in French | MEDLINE | ID: mdl-27989403

ABSTRACT

Technological progress and improved clinical knowledge have increased survival of neonates who would previously have died. Survival is sometimes accompanied by a risk of short- or long-term adverse outcomes, which may lead to complex decisions about withholding or withdrawing life-sustaining interventions. These decisions are among the most difficult decisions in pediatric practice. They also involve communicating with parents and are emotionally charged. Many articles examining end-of-life decisions in neonatology state the need for healthcare providers to be caring, compassionate, and human without offering clear, practical advice. In this article, the way in which neonates die and the ethical decision-making surrounding these decisions will be reviewed. Guidelines to reflect on the life trajectories of neonates will be offered, as well as recommendations to optimize communication with families during these difficult moments.


Subject(s)
Attitude to Death , Communication , Euthanasia, Passive/ethics , Life Support Care/ethics , Neonatology/ethics , Parents/education , Professional-Family Relations/ethics , Decision Making/ethics , Ethics, Medical , Female , France , Guideline Adherence/ethics , Humans , Infant, Extremely Low Birth Weight , Infant, Newborn , Parental Consent/ethics , Resuscitation Orders/ethics , Withholding Treatment
3.
Ann Fr Anesth Reanim ; 33(11): 572-5, 2014 Nov.
Article in French | MEDLINE | ID: mdl-25450730

ABSTRACT

OBJECTIVE: The flow rate of intravenous administration of vasoactive agents should be steady in order to prevent changes in hemodynamics. In the newborns, because the flow rate is often lower than 1mL/h, it is difficult to switch of the syringe. The aim of our study was to compare the variations of concentration of active substance delivered after a manual or an automatic switch off the syringe with three different volumes (10mL, 20mL and 50mL). MATERIALS AND METHODS: Glucose solution (10g/L) was used to simulate the administered substance. Saline was administered in "Y" simultaneously with the glucose solution through a catheter. The infused substance was collected at the tip of the catheter. The glucose concentration was measured at 15min-interval for 3hours. RESULTS: The manual switch of the syringe was associated with a significant alteration of the flow rate, lasting more than 15min. In contrast, the automatic switch of syringes was associated with no change of the flow rate, especially with small-volume syringes (10mL). CONCLUSION: In newborns, in order to prevent the change in flow rate of drugs after a switch of syringes, our results suggest the use of syringe-pump with built-in automatic switch and small-volume syringes.


Subject(s)
Infusions, Intravenous/instrumentation , Infusions, Intravenous/methods , Syringes , Vasoconstrictor Agents/administration & dosage , Automation , Catheters , Equipment Design , Female , Glucose Solution, Hypertonic/administration & dosage , Humans , Infant, Newborn , Male
4.
Arch Pediatr ; 20 Suppl 1: S11-8, 2013 Sep.
Article in French | MEDLINE | ID: mdl-23992832

ABSTRACT

The increased survival rate reached in infants with congenital diaphragmatic hernia (CDH) has shown a concomitant increase in late morbidity. Many complications including pulmonary damage, cardiovascular disease, gastro-intestinal disease, failure to thrive, neurocognitive defects and musculoskeletal abnormalities have been described. Long-term pulmonary morbidity in CDH consists of obstructive and restrictive lung function impairments due to altered lung structure and prolonged ventilatory support. Long-term consequences of pulmonary hypertension are unknown. Gastro-esophageal reflux disease (GERD) is also an important contributor to overall morbidity. Failure to thrive may be caused by GERD, insufficient intake due to oral aversion and increased caloric requirements due to pulmonary morbidity. Neurological outcome is determined by an increased risk of perinatal and neonatal hypoxemia in the first days of life of CDH patients. Many studies have addressed the substantial impact of the health problems described above, on the overall well-being of CDH patients, but only a few studies focus on the health-related quality of life. Considering the scattered data indicating substantial morbidity in long-term survivors of CDH, follow-up studies that systematically assess long-term sequelae are needed. Based on such studies, a more focused approach for routine multidisciplinary follow-up programs could be established. It is the goal of the French Collaborative Network to promote exchange of knowledge, future research and development of treatment protocols.


Subject(s)
Hernias, Diaphragmatic, Congenital , Quality of Life , Cardiovascular Diseases/etiology , Cognition Disorders/etiology , Failure to Thrive , Follow-Up Studies , France/epidemiology , Gastroesophageal Reflux/etiology , Gastrointestinal Diseases/etiology , Hernia, Diaphragmatic/complications , Hernia, Diaphragmatic/mortality , Hernia, Diaphragmatic/physiopathology , Hernia, Diaphragmatic/surgery , Humans , Infant , Infant, Newborn , Lung Diseases/etiology , Musculoskeletal Diseases/etiology , Risk Factors , Survival Rate , Treatment Outcome
5.
Rev Mal Respir ; 29(2): 337-46, 2012 Feb.
Article in French | MEDLINE | ID: mdl-22405123

ABSTRACT

Congenital diaphragmatic hernia (CDH) is a life-threatening anomaly associated with a variable degree of pulmonary hypoplasia (PH) and persistent pulmonary hypertension (PPH). Despite remarkable advances in neonatal resuscitation and intensive care, and new postnatal treatment strategies, the rates of mortality and morbidity in the newborn with CDH remain high as the result of severe respiratory failure secondary to PH and PPH. Later, lung function assessments show obstructive and restrictive impairments due to altered lung structure and lung damage due to prolonged ventilatory support. The long-term consequences of pulmonary hypertension are unknown. Other problems include chronic pulmonary aspiration caused by gastro-oesophageal reflux and respiratory manifestations of allergy such as asthma or rhinitis. Finally, failure to thrive may be caused by increased caloric requirements due to pulmonary morbidity. Follow-up studies that systematically assess long-term sequelae are needed. Based on such studies, a more focused approach for routine multidisciplinary follow-up programs could be established. It is the goal of the French Collaborative Network to promote exchange of knowledge, future research and development of treatment protocols.


Subject(s)
Hernia, Diaphragmatic/complications , Hernias, Diaphragmatic, Congenital , Bronchopulmonary Dysplasia/etiology , Failure to Thrive/etiology , Gastroesophageal Reflux/complications , Humans , Hypertension, Pulmonary/etiology , Infant, Newborn , Lung/blood supply , Pulmonary Circulation , Respiratory Insufficiency/etiology , Ventilator-Induced Lung Injury/etiology
6.
Arch Pediatr ; 17(10): 1440-4, 2010 Oct.
Article in French | MEDLINE | ID: mdl-20430598

ABSTRACT

OBJECTIVE: To evaluate prospectively the benefit of posterior liver mobilization during umbilical venous catheterization to place the umbilical venous catheter (UVC) in the central position (inferior vena cava). PATIENTS AND METHODS: Sixty-five successive newborn infants admitted in 3 neonatal intensive care units who required a UVC were enrolled over a 4-month period. UVC positions were assessed by X-ray. UVCs were placed either in an adequate position (at the right atrial-inferior vena cava junction, indicating success) or inserted within the portal system (failure). In this case, the UVC was drawn back to the 3cm mark and then, an additional attempt to insert the UVC was made during lateroposterior liver mobilization by the operator's hand. The success and failure rates at 1st and 2nd attempts were evaluated and compared. Characteristics of the population and possible catheter-related complications were recorded. RESULTS: A total of 31 of 65 (55%) UVC insertions failed at the 1st attempt. Among these UVCs, 16 (52%) were correctly repositioned in the central position by hepatic mobilization. The success rate increased by 50% (p<0.05). No life-threatening complications were observed during the procedure. CONCLUSION: Hand liver mobilization during umbilical venous catheterization improves the rate of adequate insertion of the UVC into the inferior vena cava. It is a simple, quick, and safe procedure.


Subject(s)
Catheterization/methods , Intensive Care, Neonatal/methods , Liver/anatomy & histology , Umbilical Veins , Catheterization/adverse effects , Humans , Infant, Newborn
7.
Arch Pediatr ; 17 Suppl 3: S85-92, 2010 Sep.
Article in French | MEDLINE | ID: mdl-20728814

ABSTRACT

Congenital diaphragmatic hernia (CDH) is a 1 out of 3500 live-born malformation with persistent 30-40% mortality rate, related to severe pulmonary hypoplasia and hypertension. Better knowledge on the mechanisms inducing failure of adaptation at birth is a prerequisite for improving CDH prognosis. CDH is also associated with longterm morbidity, including prolonged respiratory failure, failure to growth, oral aversion, and scoliosis. Early prevention starting as soon as the first hours of life are required to reduced long term morbidity. The aims of the management are not only to reduce early mortality, related to persistent pulmonary hypertension, but also to prevent late morbidity.


Subject(s)
Hernias, Diaphragmatic, Congenital , Infant, Newborn, Diseases/therapy , Digestive System Diseases/etiology , Digestive System Diseases/prevention & control , Hernia, Diaphragmatic/complications , Hernia, Diaphragmatic/therapy , Humans , Infant, Newborn , Respiratory Tract Diseases/etiology , Respiratory Tract Diseases/prevention & control
8.
Arch Pediatr ; 16 Suppl 1: S9-16, 2009 Sep.
Article in French | MEDLINE | ID: mdl-19836670

ABSTRACT

Severe respiratory failure results from large right to left shunting. In the newborn, both intrapulmonary and/or extrapulmonary shunting may cause severe respiratory failure. Right to left extrapulmonary shunting is associated with pulmonary hypertension (PPHN). Management depends on the main mechanism of the respiratory failure. Intrapulmonary shunting requires optimizing lung recrutment, whereas vascular recrutment is required to decrease extra-pulmonary shunting. Analysis of anamnesis, clinical examination, chest X-ray, and echocardiography allows distinguishing the mechanism of the respiratory failure. In case of PPHN, favorizing factors such as acidosis, stress, lung over distension, and polyglobuly should be treated. Inhaled NO is recommended in the treatment of PPHN after optimizing lung volume.


Subject(s)
Infant, Newborn, Diseases/drug therapy , Nitric Oxide/therapeutic use , Respiratory Insufficiency/drug therapy , Administration, Inhalation , Bronchodilator Agents/therapeutic use , Humans , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/prevention & control , Infant, Newborn , Nitric Oxide/administration & dosage , Respiratory Insufficiency/complications , Vasodilator Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL